Skip to main content

Batch recall of six products of Meyer Pharmaceuticals Ltd

  • 2024.01.26

The Department of Health (DH) today (January 26) has instructed a licensed drug manufacturer, Meyer Pharmaceuticals Ltd (Meyer), to recall the following six products (see Annex) from the market as a precautionary measure due to a quality issue.

Name of productHong Kong registration numberBatch number/Pack sizeMain use
Lyhexine CapHK-37207082208/10'srelief of cold and cough symptoms
Mecotuss CapHK-35597052104-3/1000's
relief of cold and cough symptoms
Betamin Tab*HK-32501102206-1/100s
relief of allergy symptoms
Sensoderm-S Cream*HK-36365012203/18g
treating skin infections
Xanaderm Cream*HK-41063112108/20gtreating skin infections
Mobeta Cream*HK-37738012207/20gtreating skin infections

*Prescription drugs

Upon receiving a public complaint, the DH has conducted an investigation against Meyer. The investigation revealed that the content of the active ingredients in the products failed to meet the product specifications during a long-term stability study.

While the problem identified will affect the stability of the products, it would not be harmful to user. As a precautionary measure, the DH has instructed Meyer to recall the products from the market. The DH's investigation is continuing.

According to Meyer, the products have been supplied to local private doctors, pharmacies and medicine companies. Meyer has set up a hotline (2601 2670) to answer related enquiries. The DH will closely monitor the recall.

So far, the DH has not received any adverse reaction reports in connection with the above products.

Members of the public taking the above products should consult their healthcare professionals if in doubt for appropriate arrangements.




Reposted from HKSAR Government webpage: